Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3Recruiting 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 5Interventional 3

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Breast Neoplasms 2Neoplasms 1Esophageal Neoplasms 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Histocompatibility Testing × Clear all
NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed
18 enrolled
Breast

Breast Neoplasms

NCT00319735 2016-04-28

Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas

Hoosier Cancer Research Network

Phase 2 Completed
41 enrolled 18 charts
Gastrointestinal

Esophageal Neoplasms

NCT01271738 2015-08-17

Evaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast Cancer

Emory University

Phase NA Completed
79 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡